Engaged Capital 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Engaged Capital disclosed 9 US equity positions worth $616.5m in its Q3 2024 13F filing. The largest position was EVH at 18.3% of the reported book, followed by VFC and VYX. Against the Q2 2024 filing, it opened 1 new position, added to 5 and reduced 1 among the top 9 holdings.
What did Engaged Capital own in Q3 2024? Top 9 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2024 |
|---|---|---|---|---|---|---|---|
| 1 | EVH EVOLENT HEALTH INC | Healthcare | 18.3% | $112.8m | 3,989,468 | -3% | reduced |
| 2 | VFC V F CORP | Consumer Cyclical | 17.3% | $106.6m | 5,341,368 | 0% | held |
| 3 | VYX NCR VOYIX CORPORATION | Technology | 15.8% | $97.3m | 7,171,029 | 14% | added |
| 4 | NATL NCR ATLEOS CORPORATION | Technology | 13.9% | $85.8m | 3,008,223 | 20% | added |
| 5 | PTLO PORTILLOS INC | Consumer Cyclical | 13.4% | $82.4m | 6,114,956 | 122% | added |
| 6 | BRCC BRC INC | 7.5% | $46.3m | 13,535,560 | 5% | added | |
| 7 | PRAA PRA GROUP INC | Financial Services | 6.2% | $38.1m | 1,703,512 | 0% | held |
| 8 | BL BLACKLINE INC | Technology | 5.5% | $33.6m | 609,713 | – | new |
| 9 | NEVRO CORP | 2.2% | $13.7m | 2,442,956 | 30% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.